Bleichroeder LP’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Bleichroeder LP’s Portfolio FNCH Stock Details FNCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-971	Closed	-$2.52K	–	82
2024 Q1	$2.52K	Hold	971	–	–	﹤0.01%	79
2023 Q4	$3.5K	Hold	971	–	–	﹤0.01%	71
2023 Q3	$5.03K	Hold	971	–	–	﹤0.01%	67
2023 Q2	$8.28K	Sell	971 -26,043	-96%	-$267K	﹤0.01%	77
2023 Q1	$318K	Hold	27,014	–	–	0.07%	41
2022 Q4	$389K	Hold	27,014	–	–	0.08%	41
2022 Q3	$1.35M	Hold	27,014	–	–	0.28%	34
2022 Q2	$2.3M	Hold	27,014	–	–	0.48%	31
2022 Q1	$4.08M	Hold	27,014	–	–	0.72%	31
2021 Q4	$8.08M	Hold	27,014	–	–	1.26%	21
2021 Q3	$10.5M	Hold	27,014	–	–	1.71%	18
2021 Q2	$11.4M	Hold	27,014	–	–	1.72%	18
2021 Q1	$13.1M	Buy	+27,014	New	+$13.8M	2.21%	14

Other funds holding FNCH

LSAG

Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return

Bleichroeder LP's FNCH Position: Q2 2024 in Review

Bleichroeder LP sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q2 2024, closing a stake of 971 shares — an estimated $2.52K sold.

Bleichroeder LP first reported a position in FNCH in Q1 2021 and held it in 13 quarters. The position peaked at $13.1M in Q1 2021. 1 fund tracked by Wall St. Rank holds FNCH as of Q2 2024.

Bleichroeder LP reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Bleichroeder LP sold 971 Finch Therapeutics Group, Inc. Common Stock shares in Q2 2024, an estimated $2.52K.
Bleichroeder LP first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q1 2021 and held it in 13 quarters.
Bleichroeder LP's Finch Therapeutics Group, Inc. Common Stock position peaked at $13.1M in Q1 2021.
1 fund tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q2 2024.

Based on Bleichroeder LP's 13F filing for Q2 2024, filed 13 Aug 2024.